Spotlight

Huntington’s Disease Pivotal Program Modified to Less Frequent Dosing Easing Burden on Sites and Patients
More »

Latest Updates

#TBT to our 2017 Best Biotechnology Product winners, @ionispharma and @biogen for SPINRAZA®, a treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.

.@ACCinTouch begins March 16th in New Orleans and our affiliate @Akceatx has an exciting agenda for the week. #ACC19

Follow us linkedin twitter
Ionis Clinical Trials

Clinical Trials

We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »